These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8494052)

  • 21. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presenilin 1 immunostaining using well-characterized antibodies in human tissues.
    Yamada T; Takashima A
    Exp Neurol; 1997 Nov; 148(1):10-2. PubMed ID: 9398445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
    Boutillier S; Lannes B; Buée L; Delacourte A; Rouaux C; Mohr M; Bellocq JP; Sellal F; Larmet Y; Boutillier AL; Loeffler JP
    Neurodegener Dis; 2007; 4(6):413-23. PubMed ID: 17934324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of p53 in the brains of patients with Alzheimer's disease.
    Kitamura Y; Shimohama S; Kamoshima W; Matsuoka Y; Nomura Y; Taniguchi T
    Biochem Biophys Res Commun; 1997 Mar; 232(2):418-21. PubMed ID: 9125193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A; Boom A; Leroy K; Brion JP
    FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
    Kawamoto Y; Akiguchi I; Jarius C; Budka H
    Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of clusterin in Alzheimer brain tissue.
    McGeer PL; Kawamata T; Walker DG
    Brain Res; 1992 May; 579(2):337-41. PubMed ID: 1378350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis.
    Leveugle B; Spik G; Perl DP; Bouras C; Fillit HM; Hof PR
    Brain Res; 1994 Jul; 650(1):20-31. PubMed ID: 7953673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lactoferrin in the central nervous system].
    Sacharczuk M; Zagulski T; Sadowski B; Barcikowska M; Pluta R
    Neurol Neurochir Pol; 2005; 39(6):482-9. PubMed ID: 16355306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease.
    An L; Sato H; Konishi Y; Walker DG; Beach TG; Rogers J; Tooyama I
    Neurosci Lett; 2009 Mar; 452(3):277-80. PubMed ID: 19348738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust gene dysregulation in Alzheimer's disease brains.
    Feng X; Bai Z; Wang J; Xie B; Sun J; Han G; Song F; Crack PJ; Duan Y; Lei H
    J Alzheimers Dis; 2014; 41(2):587-97. PubMed ID: 24662101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of telencephalin immunoreactivity in the brain of patients with Alzheimer's disease.
    Hino H; Mori K; Yoshihara Y; Iseki E; Akiyama H; Nishimura T; Ikeda K; Kosaka K
    Brain Res; 1997 Apr; 753(2):353-7. PubMed ID: 9125424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
    Castellani RJ; Smith MA; Nunomura A; Harris PL; Perry G
    Free Radic Biol Med; 1999 Jun; 26(11-12):1508-12. PubMed ID: 10401616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of amyloid P component with complement proteins in neurologically diseased brain tissue.
    Akiyama H; Yamada T; Kawamata T; McGeer PL
    Brain Res; 1991 May; 548(1-2):349-52. PubMed ID: 1831062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunolocalization of lactoferrin in cartilage-forming neoplasms.
    Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
    J Orthop Sci; 2009 Nov; 14(6):732-7. PubMed ID: 19997820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactoferrin-like Immunoreactivity in Distinct Neuronal Populations in the Mouse Central Nervous System.
    Shimaoka S; Hamaoka H; Inoue J; Asanuma M; Tooyama I; Kondo Y
    Acta Med Okayama; 2021 Apr; 75(2):153-167. PubMed ID: 33953422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aging and changes in brain proteins].
    Nishimura T
    Rinsho Shinkeigaku; 1982 Dec; 22(12):1115-7. PubMed ID: 7168950
    [No Abstract]   [Full Text] [Related]  

  • 40. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis.
    Olsen I; Singhrao SK
    Med Hypotheses; 2021 Jan; 146():110393. PubMed ID: 33229194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.